Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein Wnt-5a is a secreted glycoprotein that serves as a ligand for the non-canonical Wnt signaling pathways, including the Wnt/calcium and planar cell polarity (PCP) pathways (UniProt P41221). It is essential for embryonic development, where it regulates tissue morphogenesis, cell polarity, and directional cell migration (PubMed: 22824924). In adult tissues, Wnt-5a is involved in maintaining homeostasis and modulating inflammatory responses. Its role in oncology is highly context-specific; it functions as a tumor suppressor in cancers such as breast and colon cancer, but acts as a pro-metastatic oncogene in melanoma and gastric cancer (PubMed: 26911732). Therapeutic strategies involve using mimetics like Foxy-5 to activate its tumor-suppressive effects or using antagonists like Box-5 to inhibit its role in metastasis and inflammation (PubMed: 25116398).
Wnt-5a mimetics (e.g., Foxy-5) act as agonists to restore non-canonical signaling that inhibits tumor cell migration in specific cancers (PubMed: 25116398). Antagonists (e.g., Box-5) block Wnt-5a-induced signaling to prevent metastasis and inflammatory cytokine production (PubMed: 20132408).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Wnt-5a (WNT5A).